Potential links between suicide or mental health conditions and GLP-1 receptor agonists particularly semaglutide have been the focus of several recent analyses and an FDA investigation, which have shown mixed results
These compounds are known to have significant adverse effects on human health as exposure, particularly developmental exposure, has been associated with cognitive deficits, neurological disorders, reproductive abnormalities, metabolic diseases/disorders, obesity, and diabetes 5
The percentage of individuals with a weight reduction of 5% was 85%, 89%, and 91% with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% with placebo
But some people should stay away from this therapy
After 28 days, bioactivity begins to decline measurably even under proper refrigeration, so label your vial with the reconstitution date and discard any remaining solution after four weeks
the combination introduces unknown safety and efficacy risks